Eyesciences
Eyesciences is a Toronto-based startup committed to developing novel gene-based therapeutics for ocular diseases. Our lead therapeutic is a treatment for uveal melanoma, a cancer with a low survival and limited effective treatment options. By leveraging a novel pathway for cancer treatment, our therapeutic will bypass immunological hurdles involved in uveal melanoma to improve patient survival and quality of life.
Contact:
Peter Fenton – peterfenton@sympatico.ca
Cass Dedert – cjdedert1s@gmail.com
Company – info@eyesciences.ca